Dimethyl sulfoxide as an inducer of differentiation in preosteoblast MC3T3‐E1 cellsWilliam M.W. Cheung, Awc Kung|FEBS Letters|2005Cited by 43
Sustained efficacy of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: Results of a 5-year, randomized, placebo-controlled studyStuart L. Silverman, Jonathan D. Adachi, Arkadi Chines et al.|Bone|2010Cited by 9
Ocanacatib antifracture efficacy and saftey in postmenopausal women with osteoporosis: results from the phase III long-term adonacatib fracture trial (LOFT)McClung, A. Lombardi, KG Saag et al.|Open Repository and Bibliography (University of Liège)|2015Cited by 3
Safety and Tolerability of Odanacatib Therapy in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT)Socrates E. Papapoulos, Deborah M. Gurner, Michael R. McClung et al.|Data Archiving and Networked Services (DANS)|2014Cited by 3
Safety and tolerability of odanacatib therapy in postmenopausal women with osteoporosis: results from the phase III long-term odanacatib fracture trialSocrates E. Papapoulos, Deborah M. Gurner, McClung et al.|Open Repository and Bibliography (University of Liège)|2014Cited by 2